Literature DB >> 24128725

Dramatic response to crizotinib in an ALK-positive adenocarcinoma patient with disseminated intravascular coagulation.

Gouji Toyokawa1, Mitsuhiro Takenoyama, Sawori Watanabe, Ryo Toyozawa, Eiko Inamasu, Miyako Kojo, Yoshimasa Shiraishi, Yosuke Morodomi, Tomoyoshi Takenaka, Fumihiko Hirai, Masafumi Yamaguchi, Kenichi Taguchi, Takashi Seto, Yukito Ichinose.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24128725     DOI： 10.1097/JTO.0b013e3182a008ed

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  6 in total

Review 1.  Mechanisms of Acquired Resistance to ALK Inhibitors and the Rationale for Treating ALK-positive Lung Cancer.

Authors:  Hideko Isozaki; Nagio Takigawa; Katsuyuki Kiura
Journal:  Cancers (Basel)       Date:  2015-04-30       Impact factor: 6.639

Review 2.  Understanding and treating solid tumor-related disseminated intravascular coagulation in the "era" of targeted cancer therapies.

Authors:  Felice Vito Vitale; Giuseppe Sa Longo-Sorbello; Stefano Rotondo; Francesco Ferrau
Journal:  SAGE Open Med       Date:  2017-12-21

3.  Dramatic response of acute disseminated intravascular coagulation to erlotinib in a patient with lung adenocarcinoma with activating EGFR mutation.

Authors:  Jung Soo Kim; Jeong-Seon Ryu; Sang Hoon Jeon; Hyun-Jung Kim; Hae-Seong Nam; Jae Hwa Cho; Seung Min Kwak; Hong Lyeol Lee
Journal:  J Int Med Res       Date:  2017-07-21       Impact factor: 1.671

4.  Extraordinary response to crizotinib in a woman with squamous cell lung cancer after two courses of failed chemotherapy.

Authors:  Qiushi Wang; Yong He; Xin Yang; Yubo Wang; Hualiang Xiao
Journal:  BMC Pulm Med       Date:  2014-05-15       Impact factor: 3.317

Review 5.  Disseminated intravascular coagulation complicating diagnosis of ROS1-mutant non-small cell lung cancer: A case report and literature review.

Authors:  Rachel Woodford; Michel Lu; Nadine Beydoun; Wendy Cooper; Qin Liu; Jodi Lynch; Lawrence Kasherman
Journal:  Thorac Cancer       Date:  2021-07-22       Impact factor: 3.500

6.  Dramatic Response to Alectinib in a Critically Ill Elderly Patient with Lung Adenocarcinoma Due to Trousseau Syndrome and Disseminated Intravascular Coagulation.

Authors:  Noboru Hamada; Yusaku Tada; Kazuya Hisamatsu; Yukichika Yamamoto; Takafumi Yamano
Journal:  Intern Med       Date:  2021-07-17       Impact factor: 1.271
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.